Allocations
Funds advised by SK Capital Partners (SK Capital), a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, have acquired Canadian coatings company Canlak Inc, and US-based Valentus Specialty Chemicals.
SK Capital plans to merge the two businesses to form a single North American wood coatings company called Canlak Coatings, which will be headquartered in North Brunswick, New Jersey.
“The combined Company will offer a comprehensive portfolio of wood coatings products to serve the sports, commercial and residential flooring, cabinet and furniture manufacturing sectors,” says Mario Toukan, a Managing Director of SK Capital. “We see tremendous opportunity
Nordic Capital has sold its remaining shares in Nordnet, a pan-Nordic digital savings and investments platform.
Under Nordic Capital’s ownership, and in close partnership with the founding Öhman Group, Nordnet underwent significant transformative change and now offers a best-in-class customer experience in the digital savings industry with sustainable growth potential.
In November 2020, Nordnet was successfully listed on Nasdaq Stockholm at an equity value of approximately SEK24 billion. The successful listing and subsequent strong share price performance reflect the strength of Nordnet’s business and its fast growth; the result of significant improvements implemented during Nordic Capital’s ownership. On 26 May
UK wealth manager Mattioli Woods is to acquire lower-mid cap private equity house Maven Capital Partners.
The deal will allow Maven to leverage the Mattioli Woods partnership to access further capital to help boost growth and will also enhance Maven’s services and capability through access to Mattioli Woods’ advisor and client base as well as expertise in a broader range of products.
Separately Mattioli Woods is also acquiring Ludlow Wealth Management, one of the largest independent providers of investment, financial planning and pension advice in the North West of England.
There is a long-standing relationship between Maven senior management and
CORE Industrial Partners (CORE), a Chicago-based private equity firm, has acquired Marianna Beauty Holdings (Marianna), an Omaha, Nebraska-based leading developer and manufacturer of innovative hair, skin and beauty products, by portfolio company Arizona Natural Resources (ANR).
Founded in 1968, Marianna is a full-service custom manufacturer, formulator and distributor of client-tailored hair care, hand and body products, styling aids and fixatives, hair colour and dispensary products, and pet grooming products. Marianna operates a 400,000 square foot FDA-registered and cGMP-compliant facility, offering a comprehensive suite of capabilities, including research and development, packaging compatibility, preservative efficacy and micro testing, regulatory expertise, global sourcing
Frazier Healthcare Partners has closed Frazier Healthcare Growth Buyout Fund X, its 10th healthcare private equity fund focused on the middle market, a vehicle which was oversubscribed and hit its USD1.4 billion hardcap.
The capital came in from new as well as existing limited partners, including public pension funds, financial institutions, foundations and endowments, family offices, corporate pensions and sovereign wealth funds from investors based in the US, Europe, the Middle East and Asia.
“Our three decades of focusing on the healthcare industry, breadth and depth of our ecosystem and team resonated with both new and existing investors,” comments Ben Magnano,
Financial services provider iBanFirst, which delivers solutions across banking borders, has secured a growth equity investment to fund product development, international expansion and M&A, from global private equity firm Marlin, which became the fintech’s largest shareholder as a result, replacing existing business angels and some of the company’s early backers.
Through the transaction, a number of iBanFirst’s historic partners, including top-tier venture capital firm Elaia, Bpifrance Large Venture and Xavier Niel, have strengthened their existing commitments. iBanFirst CEO and Founder, Pierre-Antoine Dusoulier, will become the company’s second-largest shareholder as part of the new agreement.
The move marks a shift
Varagon Capital Partners (Varagon) is serving as Administrative Agent, Joint Lead Arranger, Joint Bookrunner and Syndication Agent on a senior secured credit facility to support the acquisition of JTM Foods, LLC (JTM) by Tenex Capital Management (Tenex).
Headquartered in Erie, PA, JTM Foods, LLC, has been producing premium quality snack pies and other sweet treats since 1985.
The Company produces JJ’s Bakery branded, co-manufactured, and private label sweet baked goods such as fruit filled snack pies, mini pies, and crispy rice treats.
MediSpend, a global technology company providing solutions for the life sciences industry, has secured a majority investment from Susquehanna Growth Equity (SGE), an entrepreneur-centric growth equity firm exclusively focused on software and information services companies.
SGE’s prior investments across the broader healthcare vertical include Evive, HMP Global, iContracts, MMIT, ProviderTrust and RLDatix. Financial terms of the investment were not disclosed.
MediSpend provides solutions for the life sciences industry, enabling some of the world’s largest pharmaceutical, medical device and emerging biotech companies to compliantly manage high-risk business functions through top-rated software and client services. The MediSpend Global Compliance Suite represents
The Riverside Company, a global private investor focused on the smaller end of the middle market, has signed a definitive agreement to sell Greenphire, a specialist in financial lifecycle management software for clinical trials, to Thoma Bravo, a software focused private equity firm.
The pending transaction is expected to close in the second quarter of this year, subject to the satisfaction of regulatory approval and customary closing conditions. Financial details were not disclosed.
Founded in 2008, Greenphire enables pharmaceutical industry leaders worldwide to run more efficient and successful clinical trials. The company’s end-to-end solutions optimise clinical trial performance by streamlining
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
Shining brighter in light of global change
Shining brighter in light of global change